<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d353">
    <sentence id="DDI-DrugBank.d353.s0" text="Ethanol:Clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and ethanol.">
        <entity id="DDI-DrugBank.d353.s0.e0" charOffset="0-6"
            type="drug" text="Ethanol"/>
        <entity id="DDI-DrugBank.d353.s0.e1" charOffset="41-50"
            type="drug" text="etretinate"/>
        <entity id="DDI-DrugBank.d353.s0.e2" charOffset="95-103"
            type="drug" text="acitretin"/>
        <entity id="DDI-DrugBank.d353.s0.e3" charOffset="109-115"
            type="drug" text="ethanol"/>
        <pair id="DDI-DrugBank.d353.s0.p0" e1="DDI-DrugBank.d353.s0.e0"
            e2="DDI-DrugBank.d353.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s0.p1" e1="DDI-DrugBank.d353.s0.e0"
            e2="DDI-DrugBank.d353.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s0.p2" e1="DDI-DrugBank.d353.s0.e0"
            e2="DDI-DrugBank.d353.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s0.p3" e1="DDI-DrugBank.d353.s0.e1"
            e2="DDI-DrugBank.d353.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s0.p4" e1="DDI-DrugBank.d353.s0.e1"
            e2="DDI-DrugBank.d353.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s0.p5" e1="DDI-DrugBank.d353.s0.e2"
            e2="DDI-DrugBank.d353.s0.e3" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s1" text="Glibenclamide: In a study of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose lowering effect of glibenclamide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects.">
        <entity id="DDI-DrugBank.d353.s1.e0" charOffset="0-12"
            type="drug" text="Glibenclamide"/>
        <entity id="DDI-DrugBank.d353.s1.e1" charOffset="56-64"
            type="drug" text="acitretin"/>
        <entity id="DDI-DrugBank.d353.s1.e2" charOffset="125-137"
            type="drug" text="glibenclamide"/>
        <entity id="DDI-DrugBank.d353.s1.e3" charOffset="142-153"
            type="group" text="sulfonylurea"/>
        <entity id="DDI-DrugBank.d353.s1.e4" charOffset="166-179"
            type="drug" text="chlorpropamide"/>
        <pair id="DDI-DrugBank.d353.s1.p0" e1="DDI-DrugBank.d353.s1.e0"
            e2="DDI-DrugBank.d353.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s1.p1" e1="DDI-DrugBank.d353.s1.e0"
            e2="DDI-DrugBank.d353.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s1.p2" e1="DDI-DrugBank.d353.s1.e0"
            e2="DDI-DrugBank.d353.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s1.p3" e1="DDI-DrugBank.d353.s1.e0"
            e2="DDI-DrugBank.d353.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s1.p4" e1="DDI-DrugBank.d353.s1.e1"
            e2="DDI-DrugBank.d353.s1.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d353.s1.p5" e1="DDI-DrugBank.d353.s1.e1"
            e2="DDI-DrugBank.d353.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s1.p6" e1="DDI-DrugBank.d353.s1.e1"
            e2="DDI-DrugBank.d353.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s1.p7" e1="DDI-DrugBank.d353.s1.e2"
            e2="DDI-DrugBank.d353.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s1.p8" e1="DDI-DrugBank.d353.s1.e2"
            e2="DDI-DrugBank.d353.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s1.p9" e1="DDI-DrugBank.d353.s1.e3"
            e2="DDI-DrugBank.d353.s1.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s2" text="Repeating the study with 6 healthy male volunteers in the absence of glibenclamide did not detect an effect of acitretin on glucose tolerance.">
        <entity id="DDI-DrugBank.d353.s2.e0" charOffset="69-81"
            type="drug" text="glibenclamide"/>
        <entity id="DDI-DrugBank.d353.s2.e1" charOffset="111-119"
            type="drug" text="acitretin"/>
        <pair id="DDI-DrugBank.d353.s2.p0" e1="DDI-DrugBank.d353.s2.e0"
            e2="DDI-DrugBank.d353.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s3" text="Careful supervision of diabetic patients under treatment with Soriatane is recommended.">
        <entity id="DDI-DrugBank.d353.s3.e0" charOffset="62-70"
            type="brand" text="Soriatane"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s4" text="Hormonal Contraceptives: It has not been established if there is a pharmacokinetic interaction between acitretin and combined oral contraceptives.">
        <entity id="DDI-DrugBank.d353.s4.e0" charOffset="0-22"
            type="group" text="Hormonal Contraceptives"/>
        <entity id="DDI-DrugBank.d353.s4.e1" charOffset="103-111"
            type="drug" text="acitretin"/>
        <entity id="DDI-DrugBank.d353.s4.e2" charOffset="117-144"
            type="group" text="combined oral contraceptives"/>
        <pair id="DDI-DrugBank.d353.s4.p0" e1="DDI-DrugBank.d353.s4.e0"
            e2="DDI-DrugBank.d353.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s4.p1" e1="DDI-DrugBank.d353.s4.e0"
            e2="DDI-DrugBank.d353.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s4.p2" e1="DDI-DrugBank.d353.s4.e1"
            e2="DDI-DrugBank.d353.s4.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s5" text="However, it has been established that acitretin interferes with the contraceptive effect of microdosed progestin minipill preparations.">
        <entity id="DDI-DrugBank.d353.s5.e0" charOffset="38-46"
            type="drug" text="acitretin"/>
        <entity id="DDI-DrugBank.d353.s5.e1" charOffset="103-111"
            type="drug" text="progestin"/>
        <pair id="DDI-DrugBank.d353.s5.p0" e1="DDI-DrugBank.d353.s5.e0"
            e2="DDI-DrugBank.d353.s5.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s6" text="Microdosed minipill progestin preparations are not recommended for use with Soriatane.">
        <entity id="DDI-DrugBank.d353.s6.e0" charOffset="20-28"
            type="drug" text="progestin"/>
        <entity id="DDI-DrugBank.d353.s6.e1" charOffset="76-84"
            type="drug" text="Soriatane"/>
        <pair id="DDI-DrugBank.d353.s6.p0" e1="DDI-DrugBank.d353.s6.e0"
            e2="DDI-DrugBank.d353.s6.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s7" text="It is not known whether other progestational contraceptives, such as implants and injectables, are adequate methods of contraception during acitretin therapy.">
        <entity id="DDI-DrugBank.d353.s7.e0" charOffset="30-58"
            type="group" text="progestational contraceptives"/>
        <entity id="DDI-DrugBank.d353.s7.e1" charOffset="140-148"
            type="drug" text="acitretin"/>
        <pair id="DDI-DrugBank.d353.s7.p0" e1="DDI-DrugBank.d353.s7.e0"
            e2="DDI-DrugBank.d353.s7.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s8" text="Methotrexate: An increased risk of hepatitis has been reported to result from combined use of methotrexate and etretinate.">
        <entity id="DDI-DrugBank.d353.s8.e0" charOffset="0-11"
            type="drug" text="Methotrexate"/>
        <entity id="DDI-DrugBank.d353.s8.e1" charOffset="94-105"
            type="drug" text="methotrexate"/>
        <entity id="DDI-DrugBank.d353.s8.e2" charOffset="111-120"
            type="drug" text="etretinate"/>
        <pair id="DDI-DrugBank.d353.s8.p0" e1="DDI-DrugBank.d353.s8.e0"
            e2="DDI-DrugBank.d353.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s8.p1" e1="DDI-DrugBank.d353.s8.e0"
            e2="DDI-DrugBank.d353.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s8.p2" e1="DDI-DrugBank.d353.s8.e1"
            e2="DDI-DrugBank.d353.s8.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s9" text="Consequently, the combination of methotrexate with acitretin is also contraindicated.">
        <entity id="DDI-DrugBank.d353.s9.e0" charOffset="33-44"
            type="drug" text="methotrexate"/>
        <entity id="DDI-DrugBank.d353.s9.e1" charOffset="51-59"
            type="drug" text="acitretin"/>
        <pair id="DDI-DrugBank.d353.s9.p0" e1="DDI-DrugBank.d353.s9.e0"
            e2="DDI-DrugBank.d353.s9.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s10" text="Phenytoin: If acitretin is given concurrently with phenytoin, the protein binding of phenytoin may be reduced.">
        <entity id="DDI-DrugBank.d353.s10.e0" charOffset="0-8"
            type="drug" text="Phenytoin"/>
        <entity id="DDI-DrugBank.d353.s10.e1" charOffset="14-22"
            type="drug" text="acitretin"/>
        <entity id="DDI-DrugBank.d353.s10.e2" charOffset="51-59"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d353.s10.e3" charOffset="85-93"
            type="drug" text="phenytoin"/>
        <pair id="DDI-DrugBank.d353.s10.p0"
            e1="DDI-DrugBank.d353.s10.e0" e2="DDI-DrugBank.d353.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s10.p1"
            e1="DDI-DrugBank.d353.s10.e0" e2="DDI-DrugBank.d353.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s10.p2"
            e1="DDI-DrugBank.d353.s10.e0" e2="DDI-DrugBank.d353.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s10.p3"
            e1="DDI-DrugBank.d353.s10.e1" e2="DDI-DrugBank.d353.s10.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d353.s10.p4"
            e1="DDI-DrugBank.d353.s10.e1" e2="DDI-DrugBank.d353.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s10.p5"
            e1="DDI-DrugBank.d353.s10.e2" e2="DDI-DrugBank.d353.s10.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s11" text="Tetracyclines: Since both acitretin and tetracyclines can cause increased intracranial pressure, their combined use is contraindicated.">
        <entity id="DDI-DrugBank.d353.s11.e0" charOffset="0-12"
            type="group" text="Tetracyclines"/>
        <entity id="DDI-DrugBank.d353.s11.e1" charOffset="26-34"
            type="drug" text="acitretin"/>
        <entity id="DDI-DrugBank.d353.s11.e2" charOffset="40-52"
            type="group" text="tetracyclines"/>
        <pair id="DDI-DrugBank.d353.s11.p0"
            e1="DDI-DrugBank.d353.s11.e0" e2="DDI-DrugBank.d353.s11.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s11.p1"
            e1="DDI-DrugBank.d353.s11.e0" e2="DDI-DrugBank.d353.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s11.p2"
            e1="DDI-DrugBank.d353.s11.e1" e2="DDI-DrugBank.d353.s11.e2"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s12" text="Vitamin A and oral retinoids: Concomitant administration of vitamin A and/or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis A.">
        <entity id="DDI-DrugBank.d353.s12.e0" charOffset="0-8"
            type="group" text="Vitamin A"/>
        <entity id="DDI-DrugBank.d353.s12.e1" charOffset="19-27"
            type="group" text="retinoids"/>
        <entity id="DDI-DrugBank.d353.s12.e2" charOffset="60-68"
            type="group" text="vitamin A"/>
        <entity id="DDI-DrugBank.d353.s12.e3" charOffset="88-96"
            type="group" text="retinoids"/>
        <entity id="DDI-DrugBank.d353.s12.e4" charOffset="103-111"
            type="drug" text="acitretin"/>
        <pair id="DDI-DrugBank.d353.s12.p0"
            e1="DDI-DrugBank.d353.s12.e0" e2="DDI-DrugBank.d353.s12.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s12.p1"
            e1="DDI-DrugBank.d353.s12.e0" e2="DDI-DrugBank.d353.s12.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s12.p2"
            e1="DDI-DrugBank.d353.s12.e0" e2="DDI-DrugBank.d353.s12.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s12.p3"
            e1="DDI-DrugBank.d353.s12.e0" e2="DDI-DrugBank.d353.s12.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s12.p4"
            e1="DDI-DrugBank.d353.s12.e1" e2="DDI-DrugBank.d353.s12.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s12.p5"
            e1="DDI-DrugBank.d353.s12.e1" e2="DDI-DrugBank.d353.s12.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s12.p6"
            e1="DDI-DrugBank.d353.s12.e1" e2="DDI-DrugBank.d353.s12.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s12.p7"
            e1="DDI-DrugBank.d353.s12.e2" e2="DDI-DrugBank.d353.s12.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s12.p8"
            e1="DDI-DrugBank.d353.s12.e2" e2="DDI-DrugBank.d353.s12.e4"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d353.s12.p9"
            e1="DDI-DrugBank.d353.s12.e3" e2="DDI-DrugBank.d353.s12.e4"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s13" text="Other: There appears to be no pharmacokinetic interaction between acitretin and cimetidine, digoxin, or glyburide.">
        <entity id="DDI-DrugBank.d353.s13.e0" charOffset="66-74"
            type="drug" text="acitretin"/>
        <entity id="DDI-DrugBank.d353.s13.e1" charOffset="80-89"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d353.s13.e2" charOffset="92-98"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d353.s13.e3" charOffset="104-112"
            type="drug" text="glyburide"/>
        <pair id="DDI-DrugBank.d353.s13.p0"
            e1="DDI-DrugBank.d353.s13.e0" e2="DDI-DrugBank.d353.s13.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s13.p1"
            e1="DDI-DrugBank.d353.s13.e0" e2="DDI-DrugBank.d353.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s13.p2"
            e1="DDI-DrugBank.d353.s13.e0" e2="DDI-DrugBank.d353.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s13.p3"
            e1="DDI-DrugBank.d353.s13.e1" e2="DDI-DrugBank.d353.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s13.p4"
            e1="DDI-DrugBank.d353.s13.e1" e2="DDI-DrugBank.d353.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s13.p5"
            e1="DDI-DrugBank.d353.s13.e2" e2="DDI-DrugBank.d353.s13.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s14" text="Investigations into the effect of acitretin on the protein binding of anticoagulants of the coumarin type (warfarin) revealed no interaction.">
        <entity id="DDI-DrugBank.d353.s14.e0" charOffset="34-42"
            type="drug" text="acitretin"/>
        <entity id="DDI-DrugBank.d353.s14.e1" charOffset="70-104"
            type="group" text="anticoagulants of the coumarin type"/>
        <entity id="DDI-DrugBank.d353.s14.e2" charOffset="107-114"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d353.s14.p0"
            e1="DDI-DrugBank.d353.s14.e0" e2="DDI-DrugBank.d353.s14.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s14.p1"
            e1="DDI-DrugBank.d353.s14.e0" e2="DDI-DrugBank.d353.s14.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d353.s14.p2"
            e1="DDI-DrugBank.d353.s14.e1" e2="DDI-DrugBank.d353.s14.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s15" text="Laboratory Tests If significant abnormal laboratory results are obtained, either dosage reduction with careful monitoring or treatment discontinuation is recommended, depending on clinical judgement."/>
    <sentence id="DDI-DrugBank.d353.s16" text="Blood Sugar: Some patients receiving retinoids have experienced problems with blood sugar control.">
        <entity id="DDI-DrugBank.d353.s16.e0" charOffset="37-45"
            type="group" text="retinoids"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s17" text="In addition, new cases of diabetes have been diagnosed during retinoid therapy, including diabetic ketoacidosis.">
        <entity id="DDI-DrugBank.d353.s17.e0" charOffset="62-69"
            type="group" text="retinoid"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s18" text="In diabetics, blood-sugar levels should be monitored very carefully."/>
    <sentence id="DDI-DrugBank.d353.s19" text="Lipids: In clinical studies, the incidence of hypertriglyceridemia was 66%, hypercholesterolemia was 33% and that of decreased HDL was 40%."/>
    <sentence id="DDI-DrugBank.d353.s20" text="Pretreatment and follow-up measurements should be obtained under fasting conditions."/>
    <sentence id="DDI-DrugBank.d353.s21" text="It is recommended that these tests be performed weekly or every other week until the lipid response to Soriatane has stabilized.">
        <entity id="DDI-DrugBank.d353.s21.e0" charOffset="103-111"
            type="brand" text="Soriatane"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s22" text="Liver Function Tests: Elevations of AST (SGOT), ALT (SGPT) or LDH were experienced by approximately 1 in 3 patients treated with Soriatane.">
        <entity id="DDI-DrugBank.d353.s22.e0" charOffset="129-137"
            type="brand" text="Soriatane"/>
    </sentence>
    <sentence id="DDI-DrugBank.d353.s23" text="It is recommended that these tests be performed prior to initiation of Soriatane therapy, at 1- to 2-week intervals until stable and thereafter at intervals as clinically indicated.">
        <entity id="DDI-DrugBank.d353.s23.e0" charOffset="71-79"
            type="brand" text="Soriatane"/>
    </sentence>
</document>
